HealthEquity Initiated at Neutral by Goldman Sachs
Goldman Sachs Initiates HealthEquity(HQY.US) With Hold Rating, Announces Target Price $108
BTIG Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $130
BTIG Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $130
HealthEquity Is Maintained at Buy by B of A Securities
HealthEquity Analyst Ratings
BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating, Announces Target Price $120
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110
Positive Buy Rating for Healthequity Amid Leadership Transition and Strategic Growth Prospects
Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $104
Healthequity (HQY) Receives a Buy From Barclays
Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $104
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110
Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $104
Barclays Reaffirms Their Buy Rating on Healthequity (HQY)
J.P. Morgan Maintains HealthEquity(HQY.US) With Buy Rating, Cuts Target Price to $106
BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110
Navigating 8 Analyst Ratings For HealthEquity
Barrington Research Maintains Outperform on HealthEquity, Maintains $105 Price Target